The Leadership Team at Gallant is responsible for steering the company’s vision and strategic direction in regenerative medicine for pets. Comprising key executives such as the CEO and CTO, this team collaborates on innovative solutions, oversees clinical development and regulatory compliance, and drives initiatives to enhance the quality of life for animals through advanced therapies. Their collective expertise ensures that Gallant remains at the forefront of the industry, prioritizing both innovation and ethical standards.
View all